Could Α-Synuclein Modulation of Insulin and Dopamine Identify a Novel Link Between Parkinson’s Disease and Diabetes as Well as Potential Therapies?

Frontiers in Molecular Neuroscience - Switzerland
doi 10.3389/fnmol.2018.00465
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Α-Synuclein: A Therapeutic Target for Parkinson’s Disease?

Pharmacological Research
Pharmacology
2008English

Correction: Targeting the Intrinsically Disordered Structural Ensemble of Α-Synuclein by Small Molecules as a Potential Therapeutic Strategy for Parkinson’s Disease

PLoS ONE
Multidisciplinary
2014English

Lack of Pathogenic Potential of Peripheral Α-Synuclein Aggregates From Parkinson’s Disease Patients

Acta neuropathologica communications
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2018English

Diabetes and Alzheimer’s Disease: A Link Not as Simple as It Seems

Neurochemical Research
MedicineBiochemistryCellularMolecular Neuroscience
2018English

Insulin as a Bridge Between Type 2 Diabetes and Alzheimer Disease €“ How Anti-Diabetics Could Be a Solution for Dementia

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2014English

Diabetes Mellitus as a Conformational Disease: A Novel Potential Therapeutic Approach

Endocrine Abstracts
2015English

Α-Synuclein and Anti-Α-Synuclein Antibodies in Parkinson’s Disease, Atypical Parkinson Syndromes, REM Sleep Behavior Disorder, and Healthy Controls

PLoS ONE
Multidisciplinary
2012English

Parkinson’s Disease Genes VPS35 and EIF4G1 Interact Genetically and Converge on Α-Synuclein

Neuron
Neuroscience
2015English

Adipokines as a Link Between Obesity and Chronic Kidney Disease

American Journal of Physiology - Renal Physiology
UrologyPhysiology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy